The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study: Clinical Studies

Yap, Timothy A., LoRusso, Patricia, Miller, Rowan E., Kristeleit, Rebecca, Paulovich, Amanda G., McMorn, Stephen, Oplustil O’Connor, Lenka, Lombardi, Benedetta, Marco-Casanova, Paola, Gangl, Eric T., Patel, Bharat, O’Connor, Mark J., Dean, Emma, Zviezdin, Roman, Plummer, Ruth

British Journal of Cancer. :1-10

Sparad:

Bibliografiska uppgifter
Titel	The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study: Clinical Studies
Författarna	Yap, Timothy A., LoRusso, Patricia, Miller, Rowan E., Kristeleit, Rebecca, Paulovich, Amanda G., McMorn, Stephen, Oplustil O’Connor, Lenka, Lombardi, Benedetta, Marco-Casanova, Paola, Gangl, Eric T., Patel, Bharat, O’Connor, Mark J., Dean, Emma, Zviezdin, Roman, Plummer, Ruth
Källa	British Journal of Cancer. :1-10

Get it

Beståndsuppgifter